Apollo Endosurgery, Inc. (APEN) director Matthew Crawford, Paid for $1999250 in Stock; S Y Bancorp (SYBT)’s Sentiment Is 1.08

S Y Bancorp Inc (SYBT) investors sentiment decreased to 1.08 in Q1 2018. It’s down -0.45, from 1.53 in 2017Q4. The ratio fall, as 41 funds increased or started new equity positions, while 38 reduced and sold holdings in S Y Bancorp Inc. The funds in our database now have: 10.54 million shares, down from 10.62 million shares in 2017Q4. Also, the number of funds holding S Y Bancorp Inc in top ten equity positions was flat from 1 to 1 for the same number . Sold All: 12 Reduced: 26 Increased: 31 New Position: 10.

Stock Yards Bancorp, Inc. operates as the bank holding firm for Stock Yards Bank & Trust Company that provides commercial and personal banking services in Louisville, Indianapolis, and Cincinnati. The company has market cap of $908.14 million. The Company’s deposit products include non-interest and interest bearing demand deposits, savings deposits, certificates of deposit, money market deposits, and time deposits. It has a 24.07 P/E ratio. The companyÂ’s loan portfolio comprises commercial and industrial, construction and development, undeveloped land, real estate mortgage, and consumer loans; and originates and sells single-family residential mortgages.

Stock Yards Bank & Trust Co holds 3.54% of its portfolio in Stock Yards Bancorp, Inc. for 906,256 shares. Walthausen & Co. Llc owns 272,348 shares or 0.94% of their US portfolio. Moreover, Champlain Investment Partners Llc has 0.32% invested in the company for 846,286 shares. The Kentucky-based Harvey Investment Co Llc has invested 0.31% in the stock. Orleans Capital Management Corp La, a Louisiana-based fund reported 7,500 shares.

The stock increased 0.13% or $0.05 during the last trading session, reaching $39.95. About 50,886 shares traded. Stock Yards Bancorp, Inc. (SYBT) has risen 6.02% since June 23, 2017 and is uptrending. It has underperformed by 6.55% the S&P500.

Since January 1, 0001, it had 60 insider purchases, and 2 insider sales for $104,648 activity.

Analysts await Stock Yards Bancorp, Inc. (NASDAQ:SYBT) to report earnings on July, 25. They expect $0.58 EPS, up 26.09% or $0.12 from last year’s $0.46 per share. SYBT’s profit will be $13.18 million for 17.22 P/E if the $0.58 EPS becomes a reality. After $0.58 actual EPS reported by Stock Yards Bancorp, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

More news for Stock Yards Bancorp, Inc. (NASDAQ:SYBT) were recently published by: Nasdaq.com, which released: “Consolidated Research: 2018 Summary Expectations for Stock Yards, Archrock, Lantheus, Steelcase, Tableau …” on June 22, 2018. Businesswire.com‘s article titled: “Stock Yards Bancorp to Participate in a Series of Investor Meetings” and published on May 31, 2018 is yet another important article.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company has market cap of $113.81 million. The firm offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It currently has negative earnings. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries.

The stock decreased 1.66% or $0.11 during the last trading session, reaching $6.5. About 66,354 shares traded or 91.18% up from the average. Apollo Endosurgery, Inc. (NASDAQ:APEN) has risen 5.38% since June 23, 2017 and is uptrending. It has underperformed by 7.19% the S&P500. Some Historical APEN News: 23/04/2018 – APOLLO ENDOSURGERY INC – SAUDI FOOD AND DRUG AUTHORITY APPROVED ORBERA365 MANAGED WEIGHT LOSS SYSTEM & ISSUED MEDICAL DEVICE MARKETING AUTHORIZATION; 03/05/2018 – Apollo Endosurgery 1Q Loss/Shr 47c; 12/03/2018 – Apollo Endosurgery Announces Conclusion of LAP-BAND Low BMI Post-Approval Study; 24/05/2018 – Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference; 23/04/2018 – Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon – ORBERA365™ – in the Kingdom of Saudi Arabia; 30/03/2018 – Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurgery, The KEYW Holding, FARO; 03/05/2018 – APOLLO ENDOSURGERY INC – QTRLY SHR LOSS $0.47; 15/03/2018 – Apollo Endosurgery Access Event Set By Northland for Mar. 22; 03/05/2018 – Apollo Endosurgery 1Q Rev $15.7M; 12/03/2018 – Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study

More notable recent Apollo Endosurgery, Inc. (NASDAQ:APEN) news were published by: Gurufocus.com which released: “Apollo Endosurgery Inc (APEN) CEO Todd Newton Bought $399998 of Shares” on June 22, 2018, also Benzinga.com with their article: “38 Stocks Moving In Wednesday’s Mid-Day Session” published on June 20, 2018, Benzinga.com published: “28 Stocks Moving In Wednesday’s Pre-Market Session” on June 20, 2018. More interesting news about Apollo Endosurgery, Inc. (NASDAQ:APEN) were released by: Bizjournals.com and their article: “Lap-Band med device company sets public offering to raise more than $20M” published on June 21, 2018 as well as Streetinsider.com‘s news article titled: “Pre-Open Movers 06/20: (CLBS) (CLPS) (WGO) Higher; (LZB) (ORCL) (SBUX) Lower (more..)” with publication date: June 20, 2018.

Stock Yards Bancorp, Inc. (NASDAQ:SYBT) Ratings Chart